Locally Advanced/Metastatic HER2 Positive Solid Tumors Clinical Trials

Locally Advanced/Metastatic HER2 Positive Solid Tumors

Explore clinical trials studying Locally Advanced/Metastatic HER2 Positive Solid Tumors. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Locally Advanced/Metastatic HER2 Positive Solid Tumors trial results

Completed

A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors

NCT04257110

Conditions: Locally Advanced/Metastatic HER2 Positive Solid Tumors
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

Sarah Cannon Research Nashville, Tennessee, United States

The Regents of NEXT Virginia, LLC Fairfax, Virginia, United States

Jiangsu Province Hospital Nanjin, Jiangsu, China

View Trial Details